Successful treatment of a critical COVID-19 patient with tocilizumab

J Formos Med Assoc. 2021 May;120(5):1276-1278. doi: 10.1016/j.jfma.2020.10.021. Epub 2020 Oct 24.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized
  • COVID-19 Drug Treatment*
  • Humans
  • SARS-CoV-2

Substances

  • Antibodies, Monoclonal, Humanized
  • tocilizumab